FDA approved Odomzo (sonidegib) capsules for the treatment of patients with locally advanced basal cell carcinoma that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy. Odomzo is marketed by Novartis Pharmaceuticals Corp.
A phase II clinical trial identified patients with a specific molecular subtype of diffuse large B-cell lymphoma that are more likely to respond to Imbruvica (ibrutinib) treatment.
Amgen submitted a supplemental New Drug Application to the FDA for Kyprolis (carfilzomib) for Injection to seek an expanded indication for the treatment of patients with relapsed multiple myeloma who have received at least one prior therapy. The sNDA is based on data from the global ENDEAVOR trial. ENDEAVOR is the first of two head-to-head... […]
THE CHILDREN’S HOSPITAL OF PHILADELPHIA will open its Buerger Center for Advanced Pediatric Care July 27, just across from the main hospital. The center is part of the newly named Raymond G. Perelman Campus. The first clinical departments to occupy the new center will be orthopedics, oncology, radiology, and otolaryngology, with other subspecialties to follow.... […]
BRUCE QUINN joined FaegreBD Consulting as a senior director with the firm’s health and biosciences team in Washington, D.C., where he leads the firm’s health markets and reimbursement strategy consulting practice. Quinn is a national leader on Medicare policy, the impact of health reform on innovation and the crafting of successful business strategies within the... […]
CARRIE KITKO joined Monroe Carell Jr. Children’s Hospital at Vanderbilt as associate professor of pediatrics and director of the Pediatric Stem Cell Transplant Program in the Division of Hematology/Oncology. Kitko was previously assistant professor of the Blood and Marrow Transplantation Program in the Department of Pediatrics and Communicable Diseases at the University of Michigan School... […]
FDA granted an Orphan Drug Designation to Anisina (ATM-3507) for neuroblastoma. Anisina is developed by Novogen Ltd.
ERIC ROHREN was named chair of radiology at Baylor College of Medicine. His appointment is effective Oct. 1. Rohren currently serves as a professor in the Departments of Nuclear Medicine and Diagnostic Radiology at MD Anderson Cancer Center, and is chief of the Section of Positron Emission Tomography. Rohren has been on the MD Anderson... […]
FDA approved Kyprolis (carfilzomib) in combination with lenalidomide and dexamethasone for the treatment of patients with relapsed multiple myeloma who have received one to three prior lines of therapy. Kyprolis is sponsored by Onyx Pharmaceuticals Inc., an Amgen subsidiary.
FDA approved Odomzo (sonidegib) capsules for the treatment of patients with locally advanced basal cell carcinoma that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy. Odomzo is marketed by Novartis Pharmaceuticals Corp.
